{
    "Emerging Targeted Agents": {
        "NRG1 Fusion": {
            "Zenocutuzumab": "Progression (See NSCL-36)",
            "Afatinib": "Progression (See NSCL-36)"
        }
    },
    "footnotes": {
        "1": "See Principles of Systemic Therapy (NSCL-F)."
    }
}